Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pemafibrate to Reduce Cardiovascular OutcoMes by Reducing Triglycerides IN patiENts With diabeTes (PROMINENT)

NCT03071692 is registered in ClinicalTrials.gov with Kowa Research Institute, Inc. as lead sponsor.

NCT NCT03071692
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03071692 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pemafibrate to Reduce Cardiovascular OutcoMes by Reducing Triglycerides IN patiENts With diabeTes (PROMINENT)
Lead sponsor
Kowa Research Institute, Inc.
Phase
Phase 3
Overall status
Terminated
Start date
March 23, 2017
Completion date
July 27, 2022
Enrollment
10,544 (actual)
Sites
888

Conditions

As the registry lists them; a condition with its own page is linked.

dyslipidemia, type2 diabetes